The Effect of GHK on Nervous System Function and Cognitive Decline
NEW ARTICLE PUBLISHED!!
Why is this so important? Age-related cognitive decline is a common problem for many elderly people, yet its cause is poorly understood. Over 99% of investigational drugs, participating in over 200 clinical trials, failed to receive approval for the treatment of Alzheimer’s disease . Even the success of a few approved drugs provides only minimal patient improvement. There is a need for new, safe, and effective therapeutics with extensive safety and efficacy data that can be developed for use in humans within the next few years.
GHK (glycyl-L-histidyl-L-lysine) is a human plasma copper-binding peptide with a stunning array of actions that appear to counter aging-associated diseases and conditions.
Read the entire peer-reviewed article at: